미국의 당뇨병 모니터링, 치료, 약물전달 시장 : 시장 규모, 동향 분석(2025-2031년) - MedSuite

The U.S. diabetes monitoring, treatment, and drug delivery market was valued at $48 billion in 2024 and is projected to grow at a CAGR of 7.3%, reaching $79 billion by 2031.

This report covers key market segments, including:

• Blood Glucose Meters, Blood Glucose Test Strips, Lancets
• Continuous Glucose Monitoring (CGM) & Flash Glucose Monitoring (FGM)
• Insulin & GLP-1 Receptor Agonists (e.g., Ozempic(R))
• Insulin Pens, Insulin Syringes, and Insulin Pumps

Key Market Segment Insights

The largest and fastest-growing segment in 2024 was the insulin and GLP-1 receptor agonist market, which accounted for the majority of total market value. The growth of GLP-1 therapies is driven by:

• Rising prevalence of type 2 diabetes and obesity
• Increased demand for innovative treatment solutions
• Advancements in therapies that address both diabetes and obesity
• Market Data Highlights

The report includes:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Market Drivers & Limiters
• Market Forecasts Until 2031 and Historical Data from 2021
• Competitive Analysis & Market Shares
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• U.S. Diabetes Market Trends
• Smart Reusable Insulin Pens: The demand for smart insulin pens is increasing due to their ability to track doses, calculate insulin requirements, and provide reminders. These devices enhance diabetes management and offer greater convenience despite higher pricing.
• Technological Advancements: Continuous improvements in CGM, insulin delivery systems, and digital health solutions are expected to drive the market forward.

Market Share Insights

Top Competitors in the U.S. Diabetes Market (2024):

1 Novo Nordisk

* Market leader in insulin and second in insulin pens.

* Top position in ultra-long-acting & ultra-rapid-acting insulin.

* Only competitor in the rapid-acting insulin market.

* GLP-1 portfolio includes Ozempic(R), Rybelsus(R), and Xultophy(R).

2 Eli Lilly

* Second-largest competitor in the insulin market.

* Leader in premixed insulin, ultra-rapid-acting insulin, and human insulin.

* GLP-1 portfolio includes Trulicity(R), Mounjaro(R), and Zepbound(R).

3 Dexcom

* Dominates the continuous glucose monitoring (CGM) market.

* Strong sales from G6(R) (FDA approval in 2018) and G7 (FDA approval in 2023).

Market Segmentation Summary

This report suite includes all relevant market data, but individual MedCore reports are available for specific segments.

Blood Glucose Meter Market

• Segmented Into: Personal & Professional

Blood Glucose Test Strip Market

• Segmented Into: Personal & Professional

Lancet Market

• Segmented Into: Personal & Professional

Continuous Glucose Monitoring (CGM) Market

• Segmented Into: Personal & Professional

Flash Glucose Monitoring (FGM) Market

• Segmented Into: Readers & Sensors

Insulin and GLP-1 Market

• Insulin Types: Long-Acting, Ultra-Long-Acting, Rapid-Acting, Ultra-Rapid-Acting, Premixed, Human
• GLP-1 Segments:

Diabetes Care: GLP-1 Injection, GLP-1 Oral

Obesity Care: GLP-1 Injection

Insulin Pen Market

• Segmented Into: Reusable Pens & Pen Needles

Insulin Syringe Market

• Segmented Into: Conventional & Safety Syringes

Insulin Pump Market

• Segmented Into: Durable, Patch, and Simple Pumps

Global Research Scope

Report Attributes and Details:

• Region: United States
• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage:

• Market Size, Market Shares, Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices

Qualitative Coverage:

• COVID-19 Impact
• Market Trends & Limiters
• Competitive Analysis & SWOT for Leading Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls & Disruptive Technologies
• Disease Overviews

Data Sources:

• Industry Leader Interviews
• Government & Regulatory Data
• Hospital & Private Sector Data
• Import & Export Records
• iData Research Internal Database

TABLE OF CONTENT

Table of Contents

List of Figures

List of Charts

Executive Summary

U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Developments

Market Trends

Market Segmentation

Key Report Updates

Version History

research methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

Disease Overview

• 2.1 Introduction
  • 2.1.1 Types of Diabetes
  • 2.1.2 Diabetes Complications
  • 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
  • 2.1.4 Signs and Symptoms
  • 2.1.5 Diabetes Monitoring
  • 2.1.6 Treatment
  • 2.1.7 Drug Delivery Systems

U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview

• 3.1 Introduction
• 3.2 Market Overview & Trend Analysis
• 3.3 Drivers and Limiters
  • 3.3.1 Market Drivers
  • 3.3.2 Market Limiters
• 3.4 Competitive Market Share Analysis
• 3.5 Mergers and Acquisitions

patient demographics AND INSTALLED BASE

• 4.1 Patient Demographics
  • 4.1.1 Diagnosed Diabetes Patient Population by Type
  • 4.1.2 Diagnosed Type 2 Diabetes Patient Population by Type
  • 4.1.3 Diagnosed Insulin-Dependent Diabetes Patient Population by Type
• 4.2 Installed Base Analysis and Forecast
  • 4.2.1 Personal Glucose Monitoring Installed Base by Segment
  • 4.2.2 Personal CGM Installed Base by Patient Type
  • 4.2.3 Insulin User Installed Base by Segment
  • 4.2.4 Durable Pump Installed Base by Diabetes Type
  • 4.2.5 Patch Pump Installed Base by Diabetes Type
  • 4.2.6 MDI Installed Base by Segment
  • 4.2.7 MDI Installed Base by Diabetes Type

Blood glucose meter Market

• 5.1 Introduction
• 5.2 Market Overview
• 5.3 Market Analysis and Forecast
  • 5.3.1 Personal Blood Glucose Meter Market
  • 5.3.2 Professional Blood Glucose Meter Market
• 5.4 Drivers and Limiters
  • 5.4.1 Market Drivers
  • 5.4.2 Market Limiters
• 5.5 Competitive Market Share Analysis

Blood Glucose test strip Market

• 6.1 Introduction
• 6.2 Market Overview
• 6.3 Market Analysis and Forecast
  • 6.3.1 Total Blood Glucose Test Strip Market
  • 6.3.2 Personal Blood Glucose Test Strip Market
    • 6.3.2.1 Medicare/Medicaid Personal Blood Glucose Test Strip Market
    • 6.3.2.2 Managed Care Personal Blood Glucose Test Strip Market
    • 6.3.2.3 Personal Cash Blood Glucose Test Strip Market
  • 6.3.3 Professional Blood Glucose Test Strip Market
• 6.4 Drivers and Limiters
  • 6.4.1 Market Drivers
  • 6.4.2 Market Limiters
• 6.5 Competitive Market Share Analysis

Lancet Market

• 7.1 Introduction
• 7.2 Market Overview
• 7.3 Market Analysis and Forecast
  • 7.3.1 Total Lancet Market
  • 7.3.2 Personal Lancet Market
  • 7.3.3 Professional Lancet Market
• 7.4 Drivers and Limiters
  • 7.4.1 Market Drivers
  • 7.4.2 Market Limiters
• 7.5 Competitive Market Share Analysis

Continuous Glucose MonitorinG Market

• 8.1 Introduction
• 8.2 Market Overview
• 8.3 Market Analysis and Forecast
  • 8.3.1 Personal Continuous Glucose Monitoring Market
    • 8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
    • 8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
    • 8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
  • 8.3.2 Professional Continuous Glucose Monitoring Market
    • 8.3.2.1 Professional Continuous Glucose Monitoring System Market
    • 8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
    • 8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
• 8.4 Drivers and Limiters
  • 8.4.1 Market Drivers
  • 8.4.2 Market Limiters
• 8.5 Competitive Market Share Analysis
  • 8.5.1 Continuous Glucose Monitoring Market Installed Base Share

Flash Glucose monitoring Market

• 9.1 Introduction
• 9.2 Market Overview
• 9.3 Market Analysis and Forecast
  • 9.3.1 Flash Glucose Monitoring Reader Market
  • 9.3.2 Flash Glucose Monitoring Sensor Market
• 9.4 Drivers and Limiters
  • 9.4.1 Market Drivers
  • 9.4.2 Market Limiters
• 9.5 Competitive Market Share Analysis

Insulin and GLP-1 Market

• 10.1 Introduction
  • 10.1.1 Insulin Types
    • 10.1.1.1 Rapid-Acting Insulin Analog
    • 10.1.1.2 Ultra-Rapid-Acting Insulin Analog
    • 10.1.1.3 Regular Human Insulin
    • 10.1.1.4 Intermediate-Acting Human Insulin
    • 10.1.1.5 Long-Acting Insulin Analog
    • 10.1.1.6 Ultra-Long-Acting Insulin Analog
    • 10.1.1.7 Premixed Insulin
• 10.2 Market Overview
• 10.3 Market Analysis and Forecast
  • 10.3.1 Insulin Market
    • 10.3.1.1 Long-Acting Insulin Market
    • 10.3.1.2 Ultra-Long-Acting Insulin Market
    • 10.3.1.3 Rapid-Acting Insulin Market
    • 10.3.1.4 Ultra-Rapid-Acting Insulin Market
    • 10.3.1.5 Premixed Insulin Market
    • 10.3.1.6 Human Insulin Market
  • 10.3.2 GLP-1 Market
    • 10.3.2.1 GLP-1 Diabetes Care Injection Market
    • 10.3.2.2 GLP-1 Diabetes Care Oral Market
    • 10.3.2.3 GLP-1 Obesity Care Injection Market
• 10.4 Drivers and Limiters
  • 10.4.1 Market Drivers
  • 10.4.2 Market Limiters
• 10.5 Competitive Market Share Analysis

Insulin pen Market

• 11.1 Introduction
• 11.2 Market Overview
• 11.3 Market Analysis and Forecast
  • 11.3.1 Reusable Pen Market
    • 11.3.1.1 Standard Reusable Pen Market
    • 11.3.1.2 Smart Reusable Pen Market
  • 11.3.2 Pen Needle Market
    • 11.3.2.1 Conventional Pen Needle Market
    • 11.3.2.2 Safety Pen Needle Market
• 11.4 Drivers and Limiters
  • 11.4.1 Market Drivers
  • 11.4.2 Market Limiters
• 11.5 Competitive Market Share Analysis

Insulin Syringe Market

• 12.1 Introduction
• 12.2 Market Overview
• 12.3 Market Analysis and Forecast
  • 12.3.1 Total Insulin Syringe Market
  • 12.3.2 Conventional Insulin Syringe Market
  • 12.3.3 Safety Insulin Syringe Market
• 12.4 Drivers and Limiters
  • 12.4.1 Market Drivers
  • 12.4.2 Market Limiters
• 12.5 Competitive Market Share Analysis

Insulin pump Market

• 13.1 Introduction
  • 13.1.1 Durable Insulin Pumps
  • 13.1.2 Patch Insulin Pumps
  • 13.1.3 Simple Insulin Pumps
• 13.2 Market Overview
• 13.3 Market Analysis and Forecast
  • 13.3.1 Durable Insulin Pump Market
    • 13.3.1.1 Durable Pump Market
    • 13.3.1.2 Infusion Set Market
    • 13.3.1.3 Pump Reservoir Market
  • 13.3.2 Patch Insulin Pump Market
    • 13.3.2.1 Patch Pump System Market
    • 13.3.2.2 Insulin Pod Market
  • 13.3.3 Simple Insulin Pump Market
• 13.4 Drivers and Limiters
  • 13.4.1 Market Drivers
  • 13.4.2 Market Limiters
• 13.5 Competitive Market Share Analysis
  • 13.5.1 Durable Insulin Pump Market
  • 13.5.2 Insulin Pump Market Installed Base Share

Abbreviations